By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > News > UBS/AT1s: erasing the past will come at a price
News

UBS/AT1s: erasing the past will come at a price

News Room
Last updated: 2023/09/18 at 12:22 PM
By News Room
Share
3 Min Read
SHARE

Receive free Lex updates

We’ll send you a myFT Daily Digest email rounding up the latest Lex news every morning.

Time heals all wounds. But bond investors wiped out by Credit Suisse’s takeover may need more than a few months before they are willing to jump into the additional tier 1 bonds that rescuer UBS hopes to sell.

It is easy to see why subordinated debt investors might be wary. They were dealt a painful blow when the Swiss bank agreed to take over its failing rival in March. Securities with a face value of $17bn were entirely wiped out. Worse, they were wiped out despite equity holders managing to retain some value, in an extraordinary upending of the traditional capital hierarchy.

Confusion over whether the decision was pinned on the terms and conditions of the bonds themselves or an emergency piece of legislation, or both, did not help. Cue market ructions, bondholder lawsuits and the resignation — for health reasons — of Urban Angehrn, the chief executive of Swiss regulator Finma. He will step down at the end of September. 

New UBS AT1s will test the short-term memory of investors. Yet fears that the Credit Suisse fiasco might permanently destroy the market are overblown. In Europe, authorities were quick to reiterate that they believed debt to be senior to equity. Spreads on a basket of AT1 securities, which ballooned following the wipeout, have fallen a third. They are now not much higher than the long-term average. Moreover, the market for new issuances has reopened. BBVA, BNP and Italy’s Intesa have all raised new capital with AT1s.

In addition, UBS is considering ways to minimise “Swiss risk” — the perception that its regulators might behave particularly aggressively towards bondholders. One idea under consideration is to offer securities convertible into equity if things go wrong. That would reduce the risk of bondholders taking a bigger haircut than shareholders. Investors may also push for a detailed definition of what, exactly, would trigger the bail-in of bondholders — the “viability event”, as it is known.

These are all helpful suggestions. Still, investors could be forgiven for some residual unease. Resolving bank crises is a dirty business and regulators typically have sweeping powers to intervene. Terms and conditions, no matter how detailed, need to be underpinned by trust. UBS is a well-capitalised bank. Even so, it may have to offer high yields to entice investors.

Read the full article here

News Room September 18, 2023 September 18, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Energy CEOs React to Iran War Impact

Watch full video on YouTube

Luxury Giants Lose Billions In Market Value Amid Middle East Conflict

Watch full video on YouTube

Takeda Pharmaceutical Company Limited (TAK) Q4 FY2025 Earnings Call Transcript

FollowPlay Earnings CallPlay Earnings Call Takeda Pharmaceutical Company Limited (TAK) Q4 FY2025…

Live: US Stock Futures Rise, Oil Prices Climb, Stock Market Coverage Mar. 30, 2026

Watch full video on YouTube

How The U.S. Fell Behind In Polar Icebreakers And Trump’s $8.6 Billion Plan To Fix It

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

News

Takeda Pharmaceutical Company Limited (TAK) Q4 FY2025 Earnings Call Transcript

By News Room
News

Osotspa Public Company Limited 2026 Q1 – Results – Earnings Call Presentation (OTCMKTS:OSOPF) 2026-05-19

By News Room
News

Fidelity International Small Cap Fund Q1 2026 Commentary (FISMX)

By News Room
News

Equinor ASA (EQNR) Shareholder/Analyst Call Prepared Remarks Transcript

By News Room
News

Credit Saison Co., Ltd. 2026 Q4 – Results – Earnings Call Presentation (OTCMKTS:CSASF) 2026-05-16

By News Room
News

ABN AMRO Stock: Cost Cuts And Capital Returns Support A Buy Rating (OTCMKTS:AAVMY)

By News Room
News

ConocoPhillips: More Upside Given Long-Term Cash Flow Tailwinds (NYSE:COP)

By News Room
News

MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?